When did Roivant Sciences report Q2 2025 earnings?

Roivant Sciences (ROIV) reported Q2 2025 earnings on November 12, 2024 before market open.

What were Roivant Sciences's Q2 2025 revenue and EPS?

Roivant Sciences reported revenue of $4.5M and diluted EPS of $-0.29 for Q2 2025.

Did Roivant Sciences beat estimates in Q2 2025?

Revenue missed the consensus estimate of $45.9M by $41.4M. EPS missed the consensus estimate of $-0.25 by $0.04.

Where can I find Roivant Sciences's Q2 2025 SEC filings?

You can read the 10-Q periodic report (0001140361-24-046019) directly on SEC EDGAR. The filing index links above go to sec.gov.

Roivant Sciences ROIV Q2 2025 earnings

Reported November 12, 2024 · Before market open

Revenue$4.5MMiss by $41.4M Diluted EPS-$0.29Miss by $0.04

Revenue estimate$45.9M

EPS estimate-$0.25

Next report

Aug 10, 2026 (in a month)

Revenue estimate$2.1M

EPS estimate-$0.33

Financials

Q2 2025

Income statement

See full

Revenue$1.6M-64.9%

Operating income-$306.2M+10.4%

Net income-$113.5M+50.7%

EPS (diluted)-$0.17+45.2%

Balance sheet

See full

Cash & equivalents$102.2M-17.2%

Total debt$98.8M+87.5%

Total equity$4.4B-15.3%

Total assets$5.1B-18.4%

Cash flow

See full

Operating cash flow-$185.7M+30.4%

CapEx$7.8M+688%

Free cash flow-$193.5M+27.7%

Valuation & ratios

Valuation

as of 09/30/24

See full

Market cap$10.33B+21.7%

Enterprise value$10.33B+22.7%

P/S508.2×+279×

Profitability

See full

Operating margin-5,659.4%-18,301pp

Net margin-1,839.6%-15,231pp

FCF margin-3,858.4%+18,809pp

Returns & leverage

See full

Return on equity-7.9%-170pp

Debt / equity0×0.0×

Current ratio33.7×+23.3×

Segments

By segment

See full

Reportable Segment$1.6M-64.9%

Versus estimates

Revenue

Q4 2026$2.5MMiss by $894.5K Q3 2026$2.0MMiss by $3.1M Q2 2026$1.6MMiss by $4.0M Q3 2025$9.0MMiss by $53.1M

Q2 2025$4.5MMiss by $41.4M

Q1 2025$55.1MBeat by $24.4M

Diluted EPS

Q4 2026-$0.36Miss by $0.10 Q3 2026-$0.24Beat by $0.06 Q2 2026-$0.28Beat by $0.04 Q3 2025-$0.13Beat by $0.11

Q2 2025-$0.29Miss by $0.04

Q1 2025-$0.18Beat by $0.06

Ask the moment Roivant Sciences reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI

Claude

Questions, answered.

When did Roivant Sciences report Q2 2025 earnings?: Roivant Sciences (ROIV) reported Q2 2025 earnings on November 12, 2024 before market open.
What were Roivant Sciences's Q2 2025 revenue and EPS?: Roivant Sciences reported revenue of $4.5M and diluted EPS of $-0.29 for Q2 2025.
Did Roivant Sciences beat estimates in Q2 2025?: Revenue missed the consensus estimate of $45.9M by $41.4M. EPS missed the consensus estimate of $-0.25 by $0.04.
Where can I find Roivant Sciences's Q2 2025 SEC filings?: You can read the 10-Q periodic report (0001140361-24-046019) directly on SEC EDGAR. The filing index links above go to sec.gov.